Cargando…

Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden

BACKGROUND: Epidemiology and transmission patterns of hepatitis C virus (HCV) are important subjects as we enter a new era of treatment with directly acting antivirals (DAAs). The highest prevalence of HCV in developed countries is found among intravenous drug users (IDUs), where unsafe needle shari...

Descripción completa

Detalles Bibliográficos
Autores principales: Danielsson, Axel, Palanisamy, Navaneethan, Golbob, Sultan, Yin, Hong, Blomberg, Jonas, Hedlund, Johan, Sylvan, Staffan, Lennerstrand, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895264/
https://www.ncbi.nlm.nih.gov/pubmed/24455107
http://dx.doi.org/10.3402/iee.v4.22251
_version_ 1782299949425229824
author Danielsson, Axel
Palanisamy, Navaneethan
Golbob, Sultan
Yin, Hong
Blomberg, Jonas
Hedlund, Johan
Sylvan, Staffan
Lennerstrand, Johan
author_facet Danielsson, Axel
Palanisamy, Navaneethan
Golbob, Sultan
Yin, Hong
Blomberg, Jonas
Hedlund, Johan
Sylvan, Staffan
Lennerstrand, Johan
author_sort Danielsson, Axel
collection PubMed
description BACKGROUND: Epidemiology and transmission patterns of hepatitis C virus (HCV) are important subjects as we enter a new era of treatment with directly acting antivirals (DAAs). The highest prevalence of HCV in developed countries is found among intravenous drug users (IDUs), where unsafe needle sharing practices provide the main route of infection. Efforts to prohibit the continuous spread of HCV among these groups have been initiated by the community services and health care providers. Our goal was to understand how HCV was transmitted among IDUs within a limited population group. We provide a retrospective study (2005–2007) of the HCV transmission patterns in a population of IDUs in the Uppsala region of Sweden. METHOD: Eighty-two serum samples were collected from IDUs in Uppsala County. Our reverse transcription nested polymerase chain reaction (RT-nested PCR) and sequencing method enabled a comprehensive genetic analysis for a broad spectrum of genotypes of two relatively conserved regions, NS5B and NS3, that encodes for the viral polymerase and protease, respectively. HCV RNA in serum samples was amplified and sequenced with in-house primers. Sequence similarities between individuals and subgroups were analyzed with maximum likelihood (ML) phylogenetic trees. Published HCV reference sequences from other geographic regions and countries were also included for clarity. RESULTS: Phylogenetic analysis was possible for 59 NS5B (72%) and 29 NS3 (35%) sequences from Uppsala patients. Additionally, we also included 15 NS3 sequences from Örebro patients, making a total of 44 NS3 sequences for the analysis. By analyzing the NS3 sequences, two transmission sets were found between the IDUs (>98% sequence identity), with one set consisting of two individuals and another set consisting of three individuals. In addition, the phylogenetic analysis done with our serum samples displayed clusters that distinguished them from the reference sequences. CONCLUSION: Our method seems to enable us to trace the HCV transmission between IDUs. Furthermore, the method is fairly independent of the time of infection because the method uses relatively conserved HCV sequence regions (i.e. NS5B and NS3).
format Online
Article
Text
id pubmed-3895264
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-38952642014-01-21 Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden Danielsson, Axel Palanisamy, Navaneethan Golbob, Sultan Yin, Hong Blomberg, Jonas Hedlund, Johan Sylvan, Staffan Lennerstrand, Johan Infect Ecol Epidemiol Original Research Article BACKGROUND: Epidemiology and transmission patterns of hepatitis C virus (HCV) are important subjects as we enter a new era of treatment with directly acting antivirals (DAAs). The highest prevalence of HCV in developed countries is found among intravenous drug users (IDUs), where unsafe needle sharing practices provide the main route of infection. Efforts to prohibit the continuous spread of HCV among these groups have been initiated by the community services and health care providers. Our goal was to understand how HCV was transmitted among IDUs within a limited population group. We provide a retrospective study (2005–2007) of the HCV transmission patterns in a population of IDUs in the Uppsala region of Sweden. METHOD: Eighty-two serum samples were collected from IDUs in Uppsala County. Our reverse transcription nested polymerase chain reaction (RT-nested PCR) and sequencing method enabled a comprehensive genetic analysis for a broad spectrum of genotypes of two relatively conserved regions, NS5B and NS3, that encodes for the viral polymerase and protease, respectively. HCV RNA in serum samples was amplified and sequenced with in-house primers. Sequence similarities between individuals and subgroups were analyzed with maximum likelihood (ML) phylogenetic trees. Published HCV reference sequences from other geographic regions and countries were also included for clarity. RESULTS: Phylogenetic analysis was possible for 59 NS5B (72%) and 29 NS3 (35%) sequences from Uppsala patients. Additionally, we also included 15 NS3 sequences from Örebro patients, making a total of 44 NS3 sequences for the analysis. By analyzing the NS3 sequences, two transmission sets were found between the IDUs (>98% sequence identity), with one set consisting of two individuals and another set consisting of three individuals. In addition, the phylogenetic analysis done with our serum samples displayed clusters that distinguished them from the reference sequences. CONCLUSION: Our method seems to enable us to trace the HCV transmission between IDUs. Furthermore, the method is fairly independent of the time of infection because the method uses relatively conserved HCV sequence regions (i.e. NS5B and NS3). Co-Action Publishing 2014-01-15 /pmc/articles/PMC3895264/ /pubmed/24455107 http://dx.doi.org/10.3402/iee.v4.22251 Text en © 2014 Axel Danielsson et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Danielsson, Axel
Palanisamy, Navaneethan
Golbob, Sultan
Yin, Hong
Blomberg, Jonas
Hedlund, Johan
Sylvan, Staffan
Lennerstrand, Johan
Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
title Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
title_full Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
title_fullStr Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
title_full_unstemmed Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
title_short Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden
title_sort transmission of hepatitis c virus among intravenous drug users in the uppsala region of sweden
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895264/
https://www.ncbi.nlm.nih.gov/pubmed/24455107
http://dx.doi.org/10.3402/iee.v4.22251
work_keys_str_mv AT danielssonaxel transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT palanisamynavaneethan transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT golbobsultan transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT yinhong transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT blombergjonas transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT hedlundjohan transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT sylvanstaffan transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden
AT lennerstrandjohan transmissionofhepatitiscvirusamongintravenousdrugusersintheuppsalaregionofsweden